CTI BioPharma to Report Second Quarter 2022 Financial Results on August 8, 2022

– Company Also Announces Participation in the BTIG Biotechnology Conference and the Stifel Biotech Summer Summit – SEATTLE, Aug. 1, 2022 /PRNewswire/ — CTI BioPharma Corp. (CTI BioPharma) (NASDAQ: CTIC) today announced that management plans to report its second quarter 2022 financial…

Click here to view original post